Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Organon & Co. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 823 | 12 | 769 | −42 |
| Shares | 199.2M | 150.3K | 198.3M | −724.7K (−0.4%) |
| Value | $5.57B | $4.25M | $4.67B | −$901.2M (−16.2%) |
12 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (71)
Institutions that held Organon & Co. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (113)
Institutions that held Organon & Co. at the end of Q4 2022 and filed for Q1 2023 without it.
Showing the largest 100 of 113 by value.
Not filed for Q1 2023 yet (12)
Institutions that held Organon & Co. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Alaska Permanent Fund Corp | 68,000 | $1.90M |
| Comerica Bank | 35,073 | $1.13M |
| Gibson Wealth Advisors LLC | 40,635 | $1.04M |
| CoreCap Advisors, LLC | 1,915 | $53.5K |
| Sargent Bickham Lagudis LLC | 1,732 | $48.3K |
| Trustcore Financial Services, LLC | 1,693 | $47.3K |
| Cornerstone Planning Group LLC | 354 | $11.1K |
| Burleson & Company, LLC | 368 | $10.3K |
| Heritage Wealth Management, LLC | 264 | $7.37K |
| Glass Jacobson Investment Advisors llc | 142 | $3.97K |
| Tyler-Stone Wealth Management | 100 | $3.00K |
| St Germain D J Co Inc | 53 | $1.48K |